Key Insights

Highlights

Success Rate

90% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

6.3%

1 terminated out of 16 trials

Success Rate

90.0%

+3.5% vs benchmark

Late-Stage Pipeline

6%

1 trials in Phase 3/4

Results Transparency

33%

3 of 9 completed with results

Key Signals

3 with results90% success

Data Visualizations

Phase Distribution

11Total
Not Applicable (4)
P 1 (2)
P 2 (4)
P 3 (1)

Trial Status

Completed9
Withdrawn3
Recruiting2
Terminated1
Unknown1

Trial Success Rate

90.0%

Benchmark: 86.5%

Based on 9 completed trials

Clinical Trials (16)

Showing 16 of 16 trials
NCT04083183Phase 1RecruitingPrimary

Total Body Irradiation and Astatine-211-Labeled BC8-B10 Monoclonal Antibody for the Treatment of Nonmalignant Diseases

NCT01137643Recruiting

Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer

NCT00816413Phase 1Withdrawn

Donor Stem Cell Transplant, Pentostatin, and Total-Body Irradiation in Treating Patients With Hematological Cancer

NCT00126672Phase 2CompletedPrimary

RAPAMYCIN FOR KIDNEY ANGIOMYOLIPOMAS

NCT00900120Withdrawn

Collecting and Storing Blood Samples From Patients With Cancer

NCT00003816Phase 2Completed

Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer

NCT00964821Completed

Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell Transplant

NCT00993694Completed

Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone

NCT00731328Phase 2Completed

Donor Stem Cell Transplant After Busulfan, Fludarabine, Methylprednisolone, and Antithymocyte Globulin in Treating Patients With Bone Marrow Failure Syndrome

NCT00733252Withdrawn

Optical Coherence Tomography of the Airway for Lung Cancer or Lung Disease

NCT00952185Not ApplicableTerminated

Influenza Vaccine in Preventing Flu in Patients Who Have Undergone Stem Cell Transplant and in Healthy Volunteers

NCT00706966Not ApplicableCompletedPrimary

MRI and Magnetic Resonance Spectroscopy Imaging in Patients Receiving Dutasteride for Benign Prostatic Hypertrophy and Low-Risk Prostate Cancer

NCT00416390Not ApplicableCompletedPrimary

Lycopene in Treating Patients With Prostate Cancer or Benign Prostatic Hyperplasia

NCT00895739Phase 2UnknownPrimary

Alemtuzumab and Low-Dose Cyclosporine in Treating Patients With Severe Aplastic Anemia or Acquired Marrow Failure

NCT00632138Phase 3CompletedPrimary

Pelvic Floor Muscle Training and Biofeedback or Standard Therapy in Men Who Have Undergone Radical Prostatectomy or Transurethral Resection of the Prostate

NCT00521430Not ApplicableCompleted

Donor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other Disease

Showing all 16 trials

Research Network

Activity Timeline